Top compounds associated with response to GS1-393G12.13


Feature Type Standardized
Nominal ANOVA
mRNA triptolide CTRPv2 pan-cancer AAC 0.054 0.1
mRNA niclosamide CTRPv2 pan-cancer AAC 0.055 0.1
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.053 0.1
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.1
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.049 0.1
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.047 0.1
mRNA myriocin CTRPv2 pan-cancer AAC -0.11 0.1
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.054 0.1
mRNA MI-1 CTRPv2 pan-cancer AAC -0.058 0.1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.1
Download CSV